Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
CAS : 75330-75-5
Ref. IN-DA005C7G
5g | Arrêté | ||
25g | Arrêté |
- Composés relatifs aux ingrédients pharmaceutiques actifs (API)
- Ingrédients pharmaceutiques actifs (API) pour la recherche
- Antibiotiques
- Produits biochimiques et réactifs
- Recherche sur le cancer
- Biologie cellulaire et moléculaire
- Composés organiques chiraux
- Activateurs et inhibiteurs d'enzymes
- Enzymes
- Autres inhibiteurs
Informations sur le produit
Nom :
Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
Synonymes :
- [u'1 alpha-Isomer Lovastatin', u'6 Methylcompactin', u'6-Methylcompactin', u'alpha-Isomer Lovastatin, 1', u'Lovastatin', u'Lovastatin, (1 alpha(S*))-Isomer', u'Lovastatin, 1 alpha Isomer', u'Lovastatin, 1 alpha-Isomer', u'Mevacor', u'Mevinolin', u'MK 803', u'MK-803', u'MK803', u'Monacolin K', u'lovastatin', u'75330-75-5', u'mevinolin', u'Mevacor', u'Lovalip', u'Monacolin K', u'Altoprev', u'Lovalord', u'Mevinacor', u'Nergadan', u'Altocor', u'Artein', u'MK-803', u'6alpha-Methylcompactin', u'Hipovastin', u'Lovastatine', u'Lovasterol', u'Cholestra', u'Closterol', u'Colevix', u'Hipolip', u'Lestatin', u'Lipivas', u'Lipofren', u'Lozutin', u'Paschol', u'Rodatin', u'Rovacor', u'Tecnolip', u'Teroltrat', u'Belvas', u'Lipdip', u'Mevlor', u'Sivlor', u'Taucor', u'Lovastatine [French]', u'Lovastatinum [Latin]', u'Lovastatina [Spanish]', u'6-alpha-Methylcompactin', u'Lovastatinum', u'Lovastatina', u'Lovastin', u'MSD 803', u'MK 803', u'6 alpha-Methylcompactin', u'UNII-9LHU78OQFD', u'MLS000069585', u'HSDB 6534', u'MFCD00072164', u'9LHU78OQFD', u'BRN 3631989', u'SMR000058779', u'(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate', u'CHEBI:40303', u'2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone', u'C24H36O5', u'Lovastatin, 98%', u'Lovastatin (Mevacor)', u'(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate', u'NCGC00023509-03', u'DSSTox_CID_784', u'EN300-52515', u'6-Methylcompactin', u'DSSTox_RID_75788', u'DSSTox_GSID_20784', u'(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate', u'(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester', u'[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate', u'1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone', u'Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-', u'Liposcler', u'Rextat', u'Monakolin K', u'(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate', u'Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-', u'CPD000673570', u'Mevacor (TN)', u'Lovastatin [USAN:BAN:INN]', u'CHEMBL503', u'Lovastatin & Primycin', u'Lovastatin (USP/INN)', u'SR-05000001880']
- (1S,3R,7S,8S)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- 6α-Methylcompactin
- 8-[2-(4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate
- Altocor
- Altoprev
- Antibiotic MB 530B
- Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester, [1S-[1α(R*),3α,7β,8β(2S*,4S*),8aβ]]-
- L 154803
- Voir d'autres synonymes
- Lestric
- Lostatin
- Lovacard
- Lovalip
- Lovastatin lactone
- Lovastation
- Lovastin
- Lovex
- Mevacor
- Mevinacor
- Mevinolin
- Mevlor
- Mk 803
- Monacolin K
- Monacolin K lactone
- Msd 803
- Msd803
- NSC 633781
- Oxy)-1-Naphthaleneheptanoicaciddelta-Lactone
- Red Yeast Rice P.E
- Sivlor
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
404.5396
Formule :
C24H36O5
Degré de pureté :
98%
Couleur/Forme :
Solid
InChI :
InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1
Code InChI :
PCZOHLXUXFIOCF-BXMDZJJMSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :